14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
Imagine an anonymous worker at a multinational’s Egypt factory contacts the global whistleblower ho...
Read More >
If the coronavirus pandemic continues to spread in the United States as it has in other countries, d...
Read More >
With last Wednesday’s categorization by the World Health Organization of COVID-19 as a pandemic, sc...
Read More >
The changed economic landscape caused by COVID-19, with a shortage of debt financing and volatility ...
Read More >
On April 29, 2020, six Bay Area counties – Alameda, Contra Costa, Marin, San Francisco, San Mateo, ...
Read More >
As the potential spread of coronavirus disease 2019 (COVID-19) in the United States becomes a very r...
Read More >